nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—Dermatitis acneiform—Vandetanib—thyroid cancer	0.0881	0.113	CcSEcCtD
Clobetasol propionate—Folliculitis—Vandetanib—thyroid cancer	0.0479	0.0616	CcSEcCtD
Clobetasol propionate—Folliculitis—Sorafenib—thyroid cancer	0.0323	0.0415	CcSEcCtD
Clobetasol propionate—Secondary infection—Epirubicin—thyroid cancer	0.0255	0.0328	CcSEcCtD
Clobetasol propionate—Secondary infection—Doxorubicin—thyroid cancer	0.0236	0.0304	CcSEcCtD
Clobetasol propionate—Dry skin—Vandetanib—thyroid cancer	0.02	0.0258	CcSEcCtD
Clobetasol propionate—Leukoderma—Epirubicin—thyroid cancer	0.0176	0.0227	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Vandetanib—thyroid cancer	0.017	0.0219	CcSEcCtD
Clobetasol propionate—Leukoderma—Doxorubicin—thyroid cancer	0.0163	0.021	CcSEcCtD
Clobetasol propionate—Pain in extremity—Sorafenib—thyroid cancer	0.0147	0.019	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.0143	0.0641	CbGpPWpGaD
Clobetasol propionate—Dry skin—Sorafenib—thyroid cancer	0.0135	0.0174	CcSEcCtD
Clobetasol propionate—Alopecia—Vandetanib—thyroid cancer	0.0134	0.0172	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Epirubicin—thyroid cancer	0.0126	0.0162	CcSEcCtD
Clobetasol propionate—Eruption—Epirubicin—thyroid cancer	0.0122	0.0157	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptors—THRB—thyroid cancer	0.012	0.0539	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.012	0.0537	CbGpPWpGaD
Clobetasol propionate—Folliculitis—Epirubicin—thyroid cancer	0.0119	0.0154	CcSEcCtD
Clobetasol propionate—Psoriasis—Epirubicin—thyroid cancer	0.0119	0.0154	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Doxorubicin—thyroid cancer	0.0117	0.015	CcSEcCtD
Clobetasol propionate—Eruption—Doxorubicin—thyroid cancer	0.0113	0.0145	CcSEcCtD
Clobetasol propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.0112	0.0503	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.0111	0.0143	CcSEcCtD
Clobetasol propionate—Folliculitis—Doxorubicin—thyroid cancer	0.011	0.0142	CcSEcCtD
Clobetasol propionate—Psoriasis—Doxorubicin—thyroid cancer	0.011	0.0142	CcSEcCtD
Clobetasol propionate—Infection—Vandetanib—thyroid cancer	0.0107	0.0137	CcSEcCtD
Clobetasol propionate—Skin disorder—Vandetanib—thyroid cancer	0.0104	0.0134	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Sorafenib—thyroid cancer	0.01	0.0129	CcSEcCtD
Clobetasol propionate—Paraesthesia—Vandetanib—thyroid cancer	0.00964	0.0124	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0095	0.0426	CbGpPWpGaD
Clobetasol propionate—Rash pustular—Epirubicin—thyroid cancer	0.0094	0.0121	CcSEcCtD
Clobetasol propionate—Stinging—Epirubicin—thyroid cancer	0.00926	0.0119	CcSEcCtD
Clobetasol propionate—Glycosuria—Epirubicin—thyroid cancer	0.00926	0.0119	CcSEcCtD
Clobetasol propionate—Pain—Vandetanib—thyroid cancer	0.00918	0.0118	CcSEcCtD
Clobetasol propionate—Alopecia—Sorafenib—thyroid cancer	0.00901	0.0116	CcSEcCtD
Clobetasol propionate—Erythema—Sorafenib—thyroid cancer	0.00887	0.0114	CcSEcCtD
Clobetasol propionate—Rash pustular—Doxorubicin—thyroid cancer	0.0087	0.0112	CcSEcCtD
Clobetasol propionate—Glycosuria—Doxorubicin—thyroid cancer	0.00857	0.011	CcSEcCtD
Clobetasol propionate—Stinging—Doxorubicin—thyroid cancer	0.00857	0.011	CcSEcCtD
Clobetasol propionate—NR3C1—Endoderm Differentiation—NKX2-1—thyroid cancer	0.00791	0.0355	CbGpPWpGaD
Clobetasol propionate—NR3C1—Transcription factor regulation in adipogenesis—RXRA—thyroid cancer	0.00791	0.0355	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00763	0.0343	CbGpPWpGaD
Clobetasol propionate—Pruritus—Vandetanib—thyroid cancer	0.00759	0.00977	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.0075	0.00965	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00746	0.0335	CbGpPWpGaD
Clobetasol propionate—Dermatitis contact—Epirubicin—thyroid cancer	0.00741	0.00954	CcSEcCtD
Clobetasol propionate—Infection—Sorafenib—thyroid cancer	0.00719	0.00926	CcSEcCtD
Clobetasol propionate—Skin disorder—Sorafenib—thyroid cancer	0.00703	0.00905	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Doxorubicin—thyroid cancer	0.00686	0.00882	CcSEcCtD
Clobetasol propionate—Rash—Vandetanib—thyroid cancer	0.00677	0.00871	CcSEcCtD
Clobetasol propionate—Dermatitis—Vandetanib—thyroid cancer	0.00676	0.0087	CcSEcCtD
Clobetasol propionate—Headache—Vandetanib—thyroid cancer	0.00672	0.00865	CcSEcCtD
Clobetasol propionate—Pain—Sorafenib—thyroid cancer	0.00619	0.00797	CcSEcCtD
Clobetasol propionate—Vascular purpura—Epirubicin—thyroid cancer	0.00609	0.00783	CcSEcCtD
Clobetasol propionate—Purpura—Epirubicin—thyroid cancer	0.00565	0.00727	CcSEcCtD
Clobetasol propionate—Vascular purpura—Doxorubicin—thyroid cancer	0.00563	0.00725	CcSEcCtD
Clobetasol propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—thyroid cancer	0.00547	0.0245	CbGpPWpGaD
Clobetasol propionate—Pain in extremity—Epirubicin—thyroid cancer	0.00544	0.00701	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Sorafenib—thyroid cancer	0.00533	0.00686	CcSEcCtD
Clobetasol propionate—Purpura—Doxorubicin—thyroid cancer	0.00523	0.00673	CcSEcCtD
Clobetasol propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—thyroid cancer	0.00522	0.0234	CbGpPWpGaD
Clobetasol propionate—Pruritus—Sorafenib—thyroid cancer	0.00512	0.00659	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptors—RXRA—thyroid cancer	0.00511	0.0229	CbGpPWpGaD
Clobetasol propionate—Pain in extremity—Doxorubicin—thyroid cancer	0.00504	0.00648	CcSEcCtD
Clobetasol propionate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.00499	0.0224	CbGpPWpGaD
Clobetasol propionate—Dry skin—Epirubicin—thyroid cancer	0.00499	0.00642	CcSEcCtD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00487	0.0218	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00476	0.0214	CbGpPWpGaD
Clobetasol propionate—Dry skin—Doxorubicin—thyroid cancer	0.00462	0.00594	CcSEcCtD
Clobetasol propionate—Rash—Sorafenib—thyroid cancer	0.00457	0.00587	CcSEcCtD
Clobetasol propionate—Dermatitis—Sorafenib—thyroid cancer	0.00456	0.00587	CcSEcCtD
Clobetasol propionate—Headache—Sorafenib—thyroid cancer	0.00454	0.00584	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Epirubicin—thyroid cancer	0.00424	0.00546	CcSEcCtD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00418	0.0187	CbGpPWpGaD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00403	0.0181	CbGpPWpGaD
Clobetasol propionate—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00393	0.00505	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.00391	0.0176	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00388	0.0174	CbGpPWpGaD
Clobetasol propionate—NR3C1—Circadian Clock—RXRA—thyroid cancer	0.0038	0.017	CbGpPWpGaD
Clobetasol propionate—Hypoaesthesia—Epirubicin—thyroid cancer	0.00375	0.00482	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Epirubicin—thyroid cancer	0.00371	0.00477	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Epirubicin—thyroid cancer	0.0037	0.00476	CcSEcCtD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—CHST14—thyroid cancer	0.00348	0.0156	CbGpPWpGaD
Clobetasol propionate—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00347	0.00446	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Doxorubicin—thyroid cancer	0.00343	0.00442	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00342	0.00441	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CDK1—thyroid cancer	0.00337	0.0151	CbGpPWpGaD
Clobetasol propionate—Alopecia—Epirubicin—thyroid cancer	0.00333	0.00428	CcSEcCtD
Clobetasol propionate—Erythema—Epirubicin—thyroid cancer	0.00328	0.00422	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptors—PPARG—thyroid cancer	0.00322	0.0145	CbGpPWpGaD
Clobetasol propionate—Alopecia—Doxorubicin—thyroid cancer	0.00308	0.00396	CcSEcCtD
Clobetasol propionate—Erythema—Doxorubicin—thyroid cancer	0.00303	0.0039	CcSEcCtD
Clobetasol propionate—NR3C1—Circadian Clock—HIF1A—thyroid cancer	0.00282	0.0127	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00277	0.00357	CcSEcCtD
Clobetasol propionate—Infection—Epirubicin—thyroid cancer	0.00266	0.00342	CcSEcCtD
Clobetasol propionate—Skin disorder—Epirubicin—thyroid cancer	0.0026	0.00334	CcSEcCtD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00258	0.0116	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00257	0.0033	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00255	0.0114	CbGpPWpGaD
Clobetasol propionate—Infection—Doxorubicin—thyroid cancer	0.00246	0.00316	CcSEcCtD
Clobetasol propionate—Skin disorder—Doxorubicin—thyroid cancer	0.0024	0.00309	CcSEcCtD
Clobetasol propionate—Paraesthesia—Epirubicin—thyroid cancer	0.0024	0.00309	CcSEcCtD
Clobetasol propionate—CYP1A1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00238	0.0107	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.00233	0.0104	CbGpPWpGaD
Clobetasol propionate—Pain—Epirubicin—thyroid cancer	0.00229	0.00294	CcSEcCtD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00227	0.0102	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Doxorubicin—thyroid cancer	0.00222	0.00286	CcSEcCtD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.00222	0.00995	CbGpPWpGaD
Clobetasol propionate—Pain—Doxorubicin—thyroid cancer	0.00212	0.00272	CcSEcCtD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00204	0.00915	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Epirubicin—thyroid cancer	0.00197	0.00254	CcSEcCtD
Clobetasol propionate—CYP1A1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00193	0.00867	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—RXRA—thyroid cancer	0.00191	0.00857	CbGpPWpGaD
Clobetasol propionate—Pruritus—Epirubicin—thyroid cancer	0.00189	0.00244	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Doxorubicin—thyroid cancer	0.00182	0.00235	CcSEcCtD
Clobetasol propionate—Pruritus—Doxorubicin—thyroid cancer	0.00175	0.00225	CcSEcCtD
Clobetasol propionate—Rash—Epirubicin—thyroid cancer	0.00169	0.00217	CcSEcCtD
Clobetasol propionate—Dermatitis—Epirubicin—thyroid cancer	0.00169	0.00217	CcSEcCtD
Clobetasol propionate—Headache—Epirubicin—thyroid cancer	0.00168	0.00216	CcSEcCtD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—THRB—thyroid cancer	0.00164	0.00736	CbGpPWpGaD
Clobetasol propionate—Rash—Doxorubicin—thyroid cancer	0.00156	0.00201	CcSEcCtD
Clobetasol propionate—Dermatitis—Doxorubicin—thyroid cancer	0.00156	0.00201	CcSEcCtD
Clobetasol propionate—Headache—Doxorubicin—thyroid cancer	0.00155	0.002	CcSEcCtD
Clobetasol propionate—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00152	0.00682	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00151	0.00678	CbGpPWpGaD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—RXRA—thyroid cancer	0.00147	0.00659	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.00146	0.00657	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.00144	0.00645	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.00142	0.00636	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.00141	0.00631	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.00137	0.00615	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.00136	0.00609	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00123	0.00553	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00122	0.0055	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.00121	0.00541	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.00114	0.00511	CbGpPWpGaD
Clobetasol propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.00113	0.00509	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.00109	0.0049	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00109	0.0049	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.00104	0.00468	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—RXRA—thyroid cancer	0.00103	0.00461	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.00099	0.00444	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.00098	0.0044	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000933	0.00419	CbGpPWpGaD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	0.000927	0.00416	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.000926	0.00416	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000907	0.00407	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000873	0.00392	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000833	0.00374	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.000816	0.00366	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—THRB—thyroid cancer	0.00079	0.00354	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—MINPP1—thyroid cancer	0.000754	0.00338	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000726	0.00326	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	0.000697	0.00313	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000696	0.00312	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000696	0.00312	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	0.000689	0.00309	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—RXRA—thyroid cancer	0.000654	0.00294	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NDUFA13—thyroid cancer	0.000641	0.00288	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000625	0.00281	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000625	0.0028	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CHST14—thyroid cancer	0.000603	0.00271	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—TPR—thyroid cancer	0.000534	0.00239	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000531	0.00238	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—MEN1—thyroid cancer	0.000502	0.00225	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—HPGD—thyroid cancer	0.000486	0.00218	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—MINPP1—thyroid cancer	0.000481	0.00216	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	0.00044	0.00198	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NDUFA13—thyroid cancer	0.000409	0.00183	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000394	0.00177	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CHST14—thyroid cancer	0.000384	0.00172	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—RXRA—thyroid cancer	0.000336	0.00151	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—HPGD—thyroid cancer	0.00031	0.00139	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—TPR—thyroid cancer	0.000279	0.00125	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	0.000275	0.00123	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000251	0.00113	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000249	0.00112	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PPARG—thyroid cancer	0.000212	0.000951	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—SLC5A5—thyroid cancer	0.000209	0.000938	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000196	0.000878	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—TPR—thyroid cancer	0.000178	0.000799	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—RXRA—thyroid cancer	0.000175	0.000788	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	0.000175	0.000786	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000171	0.000766	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000159	0.000712	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—SLC5A5—thyroid cancer	0.000133	0.000598	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000125	0.00056	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—RXRA—thyroid cancer	0.000112	0.000502	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PPARG—thyroid cancer	0.000111	0.000497	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000109	0.000488	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PTGS2—thyroid cancer	8.72e-05	0.000391	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—AKT1—thyroid cancer	8.38e-05	0.000376	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PTEN—thyroid cancer	7.6e-05	0.000341	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PPARG—thyroid cancer	7.07e-05	0.000317	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PTGS2—thyroid cancer	5.56e-05	0.000249	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PTEN—thyroid cancer	4.85e-05	0.000218	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—AKT1—thyroid cancer	4.38e-05	0.000197	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—AKT1—thyroid cancer	2.79e-05	0.000125	CbGpPWpGaD
